| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Department of General Internal Medicine (H.P., J.G.L., M.F., A.E.M.), and Center for Human Drug Research (J.B., A.F.C.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands; and Division of Endocrinology (J.D.V.), Department of Internal Medicine, General Clinical Research Center and Center for Biomathematical Technology, University of Virginia Medical School, Charlottesville, Virginia 22908
Address all correspondence and requests for reprints to: H. Pijl, M.D., Ph.D., Department of General Internal Medicine, Leiden University Medical Center, C1-R39, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: h.pijl{at}lumc.nl
Abstract
We used deconvolution analysis of 24-h plasma GH concentration
profiles (10- min sampling intervals) to appraise GH secretion rates
and elimination kinetics in obese (body mass index,
34
kg/m2) premenopausal women with large visceral fat area
(LVFA; n = 8) vs. small visceral fat area (SVFA;
n = 8) as determined by magnetic resonance imaging. The subjects
were matched for body mass index, body fat percentage, and age. The
impact of the loss of 50% of prestudy weight excess induced by caloric
restriction was assessed as well. The results were compared with those
obtained in normal weight control women (n = 8). LVFA subjects
manifested markedly (4-fold) reduced mean plasma GH levels, which was
brought about by jointly diminished basal and pulsatile GH secretion.
Moreover, visceral obesity was associated with loss of regularity of GH
release, as established by the approximate entropy statistic. In
contrast, SVFA subjects produced normal daily amounts of GH and
exhibited mean 24-h plasma GH concentrations that were similar to those
in normal weight controls. GH half-life and distribution volume were
not different among the study groups. Importantly, weight loss did not
affect the daily GH secretion rate in LVFA women, so that their mean
plasma GH concentration remained considerably reduced (
50%)
compared with controls (despite the loss of
40% of visceral fat).
Normal GH kinetics in SVFA women were not significantly influenced by
weight reduction. Thus, GH neuroregulation appears to be particularly
altered in obese women with a tendency to store fat in their visceral
adipose depot. Because weight loss did not reverse GH secretion rate in
viscerally obese women, we speculate that relative hyposomatotropism is
a primary feature of these women, which could be involved in their
tendency to preferentially store excess fat in visceral adipose
tissue.
This article has been cited by other articles:
![]() |
P. Kok, F. Roelfsema, M. Frolich, J. van Pelt, A. E. Meinders, and H. Pijl Short-Term Treatment with Bromocriptine Improves Impaired Circadian Growth Hormone Secretion in Obese Premenopausal Women J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3455 - 3461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, G. A. Reynolds, A. Iranmanesh, and C. Y. Bowers Twenty-Four Hour Continuous Ghrelin Infusion Augments Physiologically Pulsatile, Nycthemeral, and Entropic (Feedback-Regulated) Modes of Growth Hormone Secretion J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3597 - 3603. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Misra, M. A. Bredella, P. Tsai, N. Mendes, K. K. Miller, and A. Klibanski Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E385 - E392. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Utz, A. Yamamoto, L. Hemphill, and K. K. Miller Growth Hormone Deficiency by Growth Hormone Releasing Hormone-Arginine Testing Criteria Predicts Increased Cardiovascular Risk Markers in Normal Young Overweight and Obese Women J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2507 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J E Walenkamp, S. Vidarsdottir, A. M Pereira, M. Karperien, J. van Doorn, H. A van Duyvenvoorde, M. H Breuning, F. Roelfsema, M F. Kruithof, J. van Dissel, et al. Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation Eur. J. Endocrinol., February 1, 2007; 156(2): 155 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Gravholt, B. E. Hjerrild, L. Mosekilde, T. K. Hansen, L. M. Rasmussen, J. Frystyk, A. Flyvbjerg, and J. S. Christiansen Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol., October 1, 2006; 155(4): 583 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Franco, J. D Veldhuis, A. Iranmanesh, J. Brandberg, L. Lonn, B. Andersson, B.-A. Bengtsson, J. Svensson, and G. Johannsson Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity. Eur. J. Endocrinol., August 1, 2006; 155(2): 261 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Luque and R. D. Kineman Impact of Obesity on the Growth Hormone Axis: Evidence for a Direct Inhibitory Effect of Hyperinsulinemia on Pituitary Function Endocrinology, June 1, 2006; 147(6): 2754 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Glintborg, R. K. Stoving, C. Hagen, A. P. Hermann, J. Frystyk, J. D. Veldhuis, A. Flyvbjerg, and M. Andersen Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5605 - 5612. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Buijs, P. W. de Leeuw, A. J. H. M. Houben, A. A. Kroon, M. Frolich, H. Pijl, and A. E. Meinders Renal Contribution to Increased Clearance of Exogenous Growth Hormone in Obese Hypertensive Patients J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 795 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Miller, B. M. K. Biller, J. G. Lipman, G. Bradwin, N. Rifai, and A. Klibanski Truncal Adiposity, Relative Growth Hormone Deficiency, and Cardiovascular Risk J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Gleeson, C. A. Lissett, and S. M. Shalet Insulin-Like Growth Factor-I Response to a Single Bolus of Growth Hormone Is Increased in Obesity J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1061 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. van Aken, A. M. Pereira, M. Frolich, J. A. Romijn, H. Pijl, J. D. Veldhuis, and F. Roelfsema Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E63 - E70. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schurgin, S. Dolan, A. Perlstein, M. P. Sullivan, N. Aliabadi, and S. Grinspoon Effects of Testosterone Administration on Growth Hormone Pulse Dynamics in Human Immunodeficiency Virus-Infected Women J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3290 - 3297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Buijs, J. A. Romijn, J. Burggraaf, M. L. de Kam, M. Frolich, M. T. Ackermans, H. P. Sauerwein, A. F. Cohen, A. E. Meinders, and H. Pijl Glucose homeostasis in abdominal obesity: hepatic hyperresponsiveness to growth hormone action Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E63 - E68. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kok, M. M. Buijs, S. W. Kok, I. H. A. P. van Ierssel, M. Frolich, F. Roelfsema, P. J. Voshol, A. E. Meinders, and H. Pijl Acipimox enhances spontaneous growth hormone secretion in obese women Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R693 - R698. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. He, E. S. Engelson, J. B. Albu, S. B. Heymsfield, and D. P. Kotler Preferential loss of omental-mesenteric fat during growth hormone therapy of HIV-associated lipodystrophy J Appl Physiol, May 1, 2003; 94(5): 2051 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M Buijs, J. Burggraaf, C. Wijbrandts, M. L de Kam, M. Frolich, A. F Cohen, J. A Romijn, H. P Sauerwein, A E. Meinders, and H. Pijl Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism Am. J. Clinical Nutrition, March 1, 2003; 77(3): 544 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Overeem, S. W. Kok, G. J. Lammers, A. A. Vein, M. Frolich, A. E. Meinders, F. Roelfsema, and H. Pijl Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E641 - E647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Buijs, J. A. Romijn, J. Burggraaf, M. L. de Kam, A. F. Cohen, M. Frolich, F. Stellaard, A. E. Meinders, and H. Pijl Growth Hormone Blunts Protein Oxidation and Promotes Protein Turnover to a Similar Extent in Abdominally Obese and Normal-Weight Women J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5668 - 5674. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. C. M. van Dam, F. Roelfsema, F. H. Helmerhorst, M. Frolich, A. E. Meinders, J. D. Veldhuis, and H. Pijl Low Amplitude and Disorderly Spontaneous Growth Hormone Release in Obese Women with or without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4225 - 4230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Buijs, J. Burggraaf, J. G. Langendonk, R. C. Schoemaker, M. Frolich, J.-W. Arndt, A. F. Cohen, J. A. Romijn, M. T. Ackermans, H. P. Sauerwein, et al. Hyposomatotropism Blunts Lipolysis in Abdominally Obese Women J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3851 - 3858. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |